| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4180fc57a693864e2ce2dbfd64a9278 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate |
2005-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0f28b5c3024962950539c8d2a974a2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cc9d9ccd977bd83cb91adf0dd8adf58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a39362fbda1a50f2beff50e27a19b3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef3a3fa32288f1f323a7b5e3170e849c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f99606b851b4f7ce294a6f8bb5d5f2d |
| publicationDate |
2007-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20070098837-A |
| titleOfInvention |
Use of certain phenyl-naphthyl compounds that do not have significant affinity for estrogen receptor (ER) alpha or beta to protect neurons and oligodendrocytes in the treatment of multiple sclerosis |
| abstract |
The present invention is a novel use of certain SERM type phenylnaphthyl compounds that do not exhibit affinity for alpha or beta type estrogen receptors (ER) for the treatment of multiple sclerosis. |
| priorityDate |
2004-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |